Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00908323 · ClinicalTrials.gov registry record
Early Immune Responses to Vaccination - A Substudy to HVTN 205
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 47
- Enrollment target
NCT00908323: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00908323 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00908323 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
HVTN 908 is a sub study of the HIV vaccine trial, HVTN 205. The purpose of this sub study is to better understand how a person's immune system responds to vaccines, particularly HIV vaccines. More specifically, researchers will determine whether early responses in the immune system help predict strong and long-lasting immunity.
Interventions
- BIOLOGICAL MVA/HIV62 vaccine
- BIOLOGICAL JS7 DNA vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2009-07 |
| Est. Completion | 2012-07 |
What the finished NCT00908323 record still lists
NCT00908323 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which MVA/HIV62 vaccine is the first listed.
NCT00908323 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00908323 about?
NCT00908323 is a clinical study titled "Early Immune Responses to Vaccination - A Substudy to HVTN 205". HVTN 908 is a sub study of the HIV vaccine trial, HVTN 205. The purpose of this sub study is to better understand how a person's immune system responds to vaccines, particularly HIV vaccines. More specifically, researchers will determine whether early responses in the immune system help predict stro...
What is the current status of trial NCT00908323?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2009-07. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00908323?
The interventions under investigation include: MVA/HIV62 vaccine (BIOLOGICAL), JS7 DNA vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00908323?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia